The Return of the Rx to OTC Switch: Market Analysis and Product Management Strategies

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

• Scope of the Report
• Methodology
• Issues and Trends

CHAPTER TWO: RX-TO-OTC PRODUCT AND MARKET ANALYSIS

• Introduction
• Allergy and Cold
  • Market Analysis
• Antilipidemic Agents
  • Market Analysis
• Fungal Infections
  • Market Analysis
• Gastrointestinal
  • Market Analysis
• Hair Loss
  • Market Analysis
• Migraine Therapy
  • Market Analysis
• NSAIDs
  • Market Analysis
• Oral Contraceptives
  • Market Analysis
• Osteoporosis and Hormone Replacement Therapy
  • Market Analysis
• Overactive Bladder
  • Market Analysis
• Sexual Dysfunction
  • Viagra
  • Market Analysis
• Sleep Agents
  • Ambien
  • Lunesta
  • Provigil
  • Market Analysis
• Smoking Cessation
  • Nicotrol Inhalation and Nasal Spray
  • Zyban
  • Market Analysis
• Viral Infections
  • Tamiflu
  • Valtrex
  • Market Analysis
• Others
  • ReVia
  • Market Analysis

CHAPTER THREE: ISSUES AND TRENDS AFFECTING THE RX-TO-OTC SWITCH INDUSTRY

• Proposed Legislation
• Consumers and Rx-to-OTC Switches
• Direct-to-Consumer (DTC) Advertising
• Patient Safety
• FDA Again Considering Third Class of Medicines
• Insurance Reimbursement Issues
• OTC Switch Criteria and FDA Involvement
• Competition Strategies

TABLE OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

• Figure 1: Major Markets for Rx to OTC 2008 and 2010
• Figure 2: Number of New Rx-to-OTC Switches per Year 1976-2007

CHAPTER TWO: RX-TO-OTC PRODUCT AND MARKET ANALYSIS

• Figure 3: Revenue, Major Rx to OTC Categories, 2008
• Table 1: Potential Rx-to-OTC Switches, 2008-2013
• Table 2: Rx-to-OTC Market Analysis: Allergy and Cold Treatments
• Table 3: Rx-to-OTC Market Analysis: Antilipidemic Agents
• Table 4: Rx-to-OTC Market Analysis: Fungal Infection Treatments
• Table 5: Rx-to-OTC Market Analysis: Gastrointestinal Treatments
• Table 6: Rx-to-OTC Market Analysis: Hair Loss Treatments
• Table 7: Rx-to-OTC Market Analysis: Migraine Therapies
• Table 8: Rx-to-OTC Market Analysis: NSAIDs
• Table 9: Rx-to-OTC Market Analysis: Oral Contraceptives
• Table 10: Rx-to-OTC Market Analysis: Sleep Agents
• Table 11: Rx-to-OTC Market Analysis: Smoking Cessation

CHAPTER THREE: ISSUES AND TRENDS AFFECTING THE RX-TO-OTC SWITCH INDUSTRY

• Table 12 Leading Rx-to-OTC Switches 1994-2007
• Figure 1: Number of New Rx-to-OTC Switches per Year 1976-2007
• Table 13: Health Insurance Trends in the United States 2003-2006